Recent Advances in the Development of Stem‐Cell‐Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease-Reference-Cited by-同舟云学术

Recent Advances in the Development of Stem‐Cell‐Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease

Published:2021-05-08 Issue:8 Volume:36 Page:1772-1780
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Barbuti Peter A.¹^ORCID,Barker Roger A.²^ORCID,Brundin Patrik³^ORCID,Przedborski Serge¹,Papa Stella M.⁴^ORCID,Kalia Lorraine V.⁵^ORCID,Mochizuki Hideki⁶^ORCID,

Affiliation:

1. Departments of Neurology, Pathology and Cell Biology, and Neuroscience Columbia University New York New York USA

2. Department of Clinical Neuroscience and WT‐MRC Cambridge Stem Cell Institute University of Cambridge and Addenbrooke's Hospital Cambridge United Kingdom

3. Van Andel Institute Center for Parkinson's Disease, Department of Neurodegenerative Science Grand Rapids Michigan USA

4. Yerkes National Primate Research Center and Department of Neurology Emory University School of Medicine Atlanta Georgia USA

5. Division of Neurology, Department of Medicine, Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital University of Toronto Toronto Ontario Canada

6. Department of Neurology Osaka University Graduate School of Medicine Osaka Japan

Funder

Canadian Institutes of Health Research

European Commission

Lundbeckfonden

Michael J. Fox Foundation for Parkinson's Research

National Institute of Neurological Disorders and Stroke

Natural Sciences and Engineering Research Council of Canada

National Institute on Handicapped Research

Ontario Brain Institute

Rosetrees Trust

Toronto General and Western Hospital Foundation